StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Ketorolac Tromethamine

HCID 84003
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
74103-07-4
Standard-SMILES
NC(CO)(CO)CO.O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O
InChIKey
BWHLPLXXIDYSNW-UHFFFAOYSA-N
Summenformel
C19H24N2O6
Durchschnittliche Molmasse
376,4 g/mol
Monoisotopische Masse
376,16343649

Überblick

ROX-888 is ROXRO's lead compound which is currently in Phase 3 trials for the treatment of acute pain, including post-operative pain.

Namen und Bezeichner

Bevorzugter Name
Ketorolac Tromethamine
IUPAC
2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
Englischer Name
Ketorolac tromethamine
Summenformel
C19H24N2O6
Molmasse
376.41

Namen und Synonyme

Ketorolac tromethamine74103-07-4ToradolKetorolac trometamolAcularAcuvailLixidolDolacAcular LSSPRIXTarasynAcular Preservative Free
Weitere Namen anzeigen
syntexKetorolac (Toradol)Ketorolac ThromethamineKETOROLAC TROMETHAMINE SALTGodekKetanovKetorolTarazyn
DTXSID0045597NSC-7586374EVE5946BQDTXCID301476271OMIDRIA COMPONENT KETOROLAC TROMETHAMINECHEBI:6130Toronova SUIKAcunivive 15

Datenbank-Bezeichner

CAS
74103-07-4
PubChem CID
84003
DTXSID
DTXSID0045597
ChEMBL
CHEMBL1201124
UNII
4EVE5946BQ
EC Number
620-545-3

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
146 Ų
H-Brücken-Donoren
5
H-Brücken-Akzeptoren
7
Frei drehbare Bindungen
6
Schwere Atome
27
Formalladung
0
Komplexität
430

Experimentelle und physikochemische Eigenschaften

Solubility>56.5 [ug/mL] (The mean of the results at pH 7.4)
Human Drugs · 3 Einträge

Breast Feeding; Lactation; Milk, Human; Analgesic Agents; Anti-inflammatory Agents, Nonsteroidal

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section155.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
160 · 160-161 C
storage temp.
2 · 2-8°C
Löslichkeit
2 O: · H2O: 15 mg/mL stable at least one month at −20 °C., soluble
Aggregatzustand
crystalline
Farbe
White to Light yellow
Biologische Quelle
synthetic (organic)
Wasserlöslichkeit
2 O: · H2O: soluble 15mg/mL, clear, colorless to faintly yellow (stable at least one month at -20 °C.)
Merck
14 · 14,5306
Stabilität
Hygroscopic
InChI
InChI=1S/C15H13NO3.C4H11NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13;5-4(1-6,2-7)3-8/h1-7,11H,8-9H2,(H,18,19);6-8H,1-3,5H2
InChIKey
BWHLPLXXIDYSNW-UHFFFAOYSA-N
SMILES
C(N)(CO)(CO)CO.C(C1C=CC=CC=1)(C1=CC=C2C(C(=O)O)CCN12)=O
CAS Datenbank
74103 · 74103-07-4(CAS DataBase Reference)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H301 (96.9%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 64 reports by companies from 12 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Hazard Classes and CategoriesAcute Tox. 3 (96.9%)

Toxikologische Informationen

Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Ketorolac tromethamine

vLess-DILI-concern

3

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Sicherheitsdaten

wgk
3
ridadr
UN 2811 6.1/PG 3
hs_code
2933995500
RTECS-Nr.
UY7759900
risk_code
25-36/37/38-23/24/25
hazard_code
T
safety_code
26-45-36/37/39
hazard_class
6.1(a)
packing_group
II
Speicherklasse
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
Acute Tox. 3 OralEye Irrit. 2Skin Irrit. 2STOT SE 3

Chemie und Industrie

Pharmakologische Informationen

Mechanism of Action · 1 Eintrag

ROX-888 is a intranasal formulation of the broadly used injectible analgesic, ketorolac. It has ability to provide effective analgesia in acute medical conditions resulting in moderate-severe pain, without the disabling side effects of opioid analgesics

FDA Pharmacological Classification · 2 Einträge

KETOROLAC TROMETHAMINE

Nonsteroidal Anti-inflammatory Drug [EPC]; Cyclooxygenase Inhibitor [EPC]; Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]

MeSH Pharmacological Classification · 2 Einträge

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.

Anwendungen · 2 Einträge

BeschreibungKetorolac tromethamine is a nonsteroidal antiinflammatory agent that exhibits analgesic and antipyretic activity. The compound is effective in the management of moderate to severe postoperative pain. It is, however, the first of this type of agent to be administered parenterally as an analgesic and is specifically indicated for intramuscular injection. Ketorolac represents a useful alternative to the narcotic analgesics due to its lack of abuse potential.

VerwendenCyclo-oxygenase inhibitor; analgesic; anti-inflammatory.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

MethylmagnesiumchloridDiethylene Glycol Dibutyl EtherBenzoylchloridPhosphortribromidNatriumhydroxid3-EthylanilinN,N-Diethylethanamin4-ChlorbutyrylchloridPhosphorus oxychlorideBis(2-methoxyethyl)etherPyrrolPhosphorylchlorid
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: An organoammonium salt resulting from the mixture of equimolar amounts of ketorolac and tromethamine (tris). It has potent non-sedating analgesic and moderate anti-inflammatory effects. It is used in the short-term management of post-operative pain, and in eye drops to relieve the ocular itching associated with seasonal allergic conjunctivitis.

Zugehörige Reaktionen

7
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 430838
HRID 430838als Produkt
Reaktionsgleichung von HRID 636077
HRID 636077als Produkt
Reaktionsgleichung von HRID 636078
HRID 636078als Produkt
Reaktionsgleichung von HRID 636079
HRID 636079als Produkt
Reaktionsgleichung von HRID 636080
HRID 636080als Produkt
Reaktionsgleichung von HRID 1531415
HRID 1531415als Produkt
Reaktionsgleichung von HRID 1534756
HRID 1534756als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung